"Hello, Mr. Eric, Miss Amy. Pen & Fun & Pavilion www.biquge.info"

Kindler was the first to stand up and say hello, with a warm smile on his face.

"Hello, Mr. Kindler." Lotus walked in with a smile on her face, and the two shook hands. He looked at the middle-aged man next to him again, stretched out his hand and smiled, "Presumably this is Mr. Donald, right?" Fortunately. ”

"Hello, Mr. Eric." Donald shook his hands with a little gratitude, and he had considerable expectations for this cooperation.

Li Jiani also smiled politely at the two, she was bored staying upstairs, so she simply followed.

"You may be seated." Lotus motioned to the two of them and sat down with Li Jiani.

"Mr. Eric," Kindler exclaimed, looking around, "you're so nice here, it's breathtaking." ”

"Thank you." Lotus smiled slightly, although the internal design of LH Biotech is exquisite, it cannot be compared with a super-large R&D base like Pfizer.

"Mr. Kindler, have you confirmed it?"

Although this was the first meeting between the two parties, Pfizer couldn't wait to contact LH since the academic journal published the report. They wanted to take the lead first, and Lotus also intended to authorize, so they pulled and pulled for a few rounds. Prior to this meeting, Pfizer had already received some sample technology.

"Yes, it's perfect." Kindler nodded, they repeatedly verified LH's technology in their own way, and in the end they were all safe reports. The opportunity should not be missed, and the matter of negotiation is really put on the bright side.

"But.." He glanced at Donald with some hesitation.

Donald shook his head slowly.

"But what?" Lotus looked at him without waves and asked, "Is it about the FDA?" ”

"Of course not, we believe in LH's technology." Kindler smiled, he was going to press on the fact that the clinical trial didn't take place. But when the words came to his lips, he held them back, and the FDA had already approved it, but they didn't carry it out. What's more, as far as he knows, there are not a few pharmaceutical giants who have contacted Eric, and this young man seems to be refusal.

"That's for the best." Lotus nodded, the human clinical object is still being selected, this does not mean that it is just over if you find someone to cure it. The goal must have a certain degree of visibility, and can cooperate with publicity, coupled with the exposure of project cooperation news, which can attract the highest attention.

Kindler glanced at his assistant, who hurriedly handed over the folder.

"Mr. Eric, that's what we're trying to do."

Lotus took it and flipped it open, and quickly glanced at the homepage, he raised his head in surprise, "Isn't there a mistake?" ”

"Of course." Kindler replied in the affirmative, a confident smile on his face.

"That's not realistic, is it?" Lotus didn't continue to look at it, he looked at Jindeler helplessly, "Nine stem cell technologies? ”

"As far as I know, Pfizer's net profit for the year is $8.12 billion." Lotus looked at him funny, "Can Pfizer afford the investment of nine stem cells?" ”

"Mr. Eric, please read on." Kindler didn't respond, he knew that Eric was right, the cooperation between the nine stem cell technologies was too big, and Pfizer couldn't give up the original investment in drug research for stem cells. However, they also thought of some solutions.

Lotus shrugged and flipped through the papers again.

moment

"Mr. Kindler, what do I see?" Lotus looked at him with a smile and a smile, "Why did LH Biotech choose this way of cooperation?" ”

This is not what he wants, he intends to license 3 stem cell technologies to Pfizer, and Pfizer will pay 2.5 billion US dollars to buy LH's 3 technologies and set up a sub-brand specializing in the production of these three stem cells. The percentage of shares and future sales share can be negotiated.

But what is it now? Pfizer's 7% stake plus $2 billion in exchange for 9 stem cell technologies, and the sub-brand he owns 75% of the shares. To be honest, if you look at Pfizer's market capitalization, a 7% stake is worth about $15 billion. From the perspective of value alone, lotus is actually earned. But he has no interest in Pfizer's stake at all, and the value of various stem cell technologies cannot be compared, such as cancer and arthritis, can this be the same?

Kindler and Donald looked at each other, their hearts full of doubts. In their perception, this kind of cooperation is already very sincere. Pfizer has set foot in the field of stem cells with LH's technological achievements, and its market value will inevitably rise. It even has the potential to replicate Apple's miracles. At that time, the value of 7% of Eric's shares can be imagined. But the premise of all this is to tie him to Pfizer.

There's nothing wrong with Pfizer's plan, it's just that they didn't expect Eric to be uninterested in shares.

Lotus sighed in her heart, these old guys, they have all their ideas on the stock market. If he really agrees to this plan, then LH Biotech will inevitably contribute to the cooperation of these nine technologies, which also solves the problem of Pfizer's capital turnover and R&D experts. But what they don't know at all is that this small company is only supported by Lotus and Gao Meinan. Uh, and there's a halfway monk, Bruce. Anyway, Pfizer's plan is completely empty.

"Mr. Eric, I think..." Kindler was ready to give him an analysis of the pros and cons.

Lotus interrupted him with a wave of his hand, he took out the prepared cooperation agreement and handed it over, and said sincerely: "This is a condition that I can accept." ”

Kindler took it with a puzzled look on his face, the agreement was very short, and after he read it, he handed it to Donald, lost in thought.

Donald looked at it carefully, his eyes full of puzzlement, he couldn't understand Eric's approach at all. It's not that they can't accept this agreement, but why not cooperate on all sides?

"Mr. Eric, I need to think about it." There is nothing wrong with this agreement, but there are too few three technologies, Kindler said in a deep voice. Pfizer takes less, and other pharmaceutical giants have an opportunity. And he needed to figure out why Eric would turn down the offer for shares.

"We'll get back to you as soon as possible." He emphasized.

"Okay." Lotus stood up unhurriedly, it was not only Pfizer who wanted to cooperate with him, and he could not only cooperate with Pfizer, now it depends on which pharmaceutical giant is more efficient.

"Mr. Franklin should still be outside." As he walked, Kindler asked, "Is he here for stem cells too?" ”

"Oh? Is it still there? Lotus was slightly surprised, he shrugged his shoulders and smiled, "Maybe." ”

Kindler smiled slightly, turned around and shook Lotus's hand, "Mr. Eric, then we'll take our leave first." ”

"Yes." (To be continued.) )